Although the observed differences in PFS by PMI/SMI risk group did not reach statistical significance, the deleterious impact of sarcopenia was particularly evident for OS ( Fig. 3 , right).
← all excerpts
Influence of Adipose Tissue Distribution, Sarcopenia, and Nutritional Status on Clinical Outcomes After CD19 CAR T-cell Therapy.
1
—
—